CSIMarket


Biora Therapeutics Inc   (BIOR)
Other Ticker:  
 


 

Biora Therapeutics Inc

BIOR's Financial Statements and Analysis



Biora Therapeutics Inc increased third quarter of 2023 net loss per share of $-4.89 compare to net loss per share of $-0.03 recorded in the same quarter a year ago a decrease compare to $-1.47 realized in previous quarter.


third quarter of 2023
Earnings Per Share Revenues
$ -4.89 $  0 Mill
$-4.86     Unch.    



Biora Therapeutics Inc 's Revenue fell by 0 % in third quarter of 2023 (Sep 30 2023) year on year, to $0 million and declined by sequentially.


Biora Therapeutics Inc is

More on BIOR's Income Statement



Biora Therapeutics Inc in the third quarter of 2023 recorded net loss of $-73.454 million, an increase from net loss of $-5.114 million in III. Quarter a year ago.

Sequentially net loss advanced

More on BIOR's Growth

Biora Therapeutics Inc Inventories
In Sep 30 2023 company's net cash and cash equivalents decreased by $-14 million, capital expenditures grew by -0.164-99.39%, to $0 millions compare to same quarter a year ago

More on BIOR's Cash flow Statement


Biora Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Biora Therapeutics Inc payed $ -3.05 cash per share, on a free-cash flow basis .


Tangible Book value grew to $ -8.31 per share from $ -10.45.

Company issued 2.88 million shares or 23.73 % in Sep 30 2023.


More on BIOR's Dividends

 Market Capitalization (Millions) 10
 Shares Outstanding (Millions) 15
 Total Debt (Millions $) 80
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -122
 Cash Flow (TTM) (Millions $) -24
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Biora Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Biora Therapeutics Inc had negative $ -3.05 cash flow per share, on a free-cash flow basis .


Tangible Book value grew to $ -8.31 per share from $ -10.45.

Company issued 2.88 million shares or 23.73 % in Sep 30 2023.


More on BIOR's Balance Sheets

 Market Capitalization (Millions) 10
 Shares Outstanding (Millions) 15
 Total Debt (Millions $) 80
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -122
 Cash Flow (TTM) (Millions $) -24
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Biora Therapeutics Inc Earnings

Impressive Revenue Growth: Companyns Show Consistent Performance in Third Quarter of 2023

Despite Biora Therapeutics Inc experiencing a deficit per share increase and a net deficit for the July to September 30, 2023 period, there is still reason for optimism in the stock market. With a recent notable move by Athyrium Capital Management, a prominent investment firm, to enhance its equity exposure through a convertible notes exchange, confidence in the market is growing.
The convertible notes exchange executed by Athyrium Capital Management at a significant 44% premium to the closing price on September 18, 2023, showcases their belief in the prevailing market conditions. This strategic decision comes at a time when the investment landscape is cautiously optimistic, and Athyrium Capital Manageme...

Biora Therapeutics Inc Faces Daunting Challenges in the Second Quarter of 2023 Earnings Season with Plummeting Revenue and Widening Net Losses

Biora Therap...

Biora Therapeutics Inc: Major Pharmaceutical Preparations Company Reports Devastating First Quarter Revenue Plunge

Biora The...


Date modified: 2023-11-14T21:49:27+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com